Timothy D. Radstake
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 20, 2020
Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).
Journal: Clinical and experimental rheumatology
Published: May 06, 2019
Quantification of Double Stranded DNA Breaks and Telomere Length as Proxies for Corneal Damage and Replicative Stress in Human Keratoconus Corneas.
Journal: Translational vision science & technology
Published: November 29, 2018
Long-term outcome of eosinophilic fasciitis: A cross-sectional evaluation of 35 patients.
Journal: Journal of the American Academy of Dermatology
Published: February 16, 2017
Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses ex vivo.
Journal: Oncoimmunology
Published: October 31, 2016
Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use.
Journal: Annals of the rheumatic diseases
Published: September 07, 2016
Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?
Journal: Nature reviews. Rheumatology
Published: August 20, 2016
Cellular Therapies in Systemic Sclerosis: Recent Progress.
Journal: Current rheumatology reports
Published: March 05, 2016
Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to Methotrexate.
Journal: Acta dermato-venereologica
Published: November 20, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026